US Pharma MarketingA global health cash crunch could jeopardize the race for new Ebola vaccines
CEPI has funneled $100M across five-plus Ebola vaccine candidates, including Moderna and Hilleman Labs, but says it still needs $128M to keep pace. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The…
A rapidly growing outbreak of Ebola in Africa has prompted a race to develop new vaccines against the virus, even as a crucial organization spearheading the effort is low on funds.
The financial reality has ...
Source: Endpoints News